

Learn which medications, supplements, and substances can interact with Emtricitabine, what to avoid, and what to tell your doctor before starting treatment.
When you're taking Emtricitabine as part of your HIV treatment, it's important to know which other medications, supplements, and substances could cause problems. While Emtricitabine has fewer drug interactions than many other antiretrovirals, there are still some important ones to watch out for.
This guide covers the most significant Emtricitabine interactions, what to avoid, and what to tell your doctor before starting treatment.
Drug interactions happen when one medication affects how another works. This can happen in several ways:
Emtricitabine is primarily eliminated through the kidneys, not the liver. This means it has fewer interactions with the liver enzyme (CYP450) pathways that cause problems for many other drugs. However, anything that affects kidney function can potentially interact with Emtricitabine.
This is the most important interaction to know about. Lamivudine and Emtricitabine are extremely similar drugs — both are cytidine analogs that work by the same mechanism and share the same resistance mutations. Taking them together provides no additional benefit and increases the risk of side effects. Your doctor will prescribe one or the other, never both.
Emtricitabine is included in many combination HIV pills: Truvada, Descovy, Atripla, Complera, Stribild, Genvoya, Odefsey, Biktarvy, and Symtuza. If you're taking standalone Emtricitabine, you must not also take any of these combination products — you'd be getting a double dose of Emtricitabine.
Since Emtricitabine is cleared by the kidneys, drugs that reduce kidney function can increase Emtricitabine levels in your body and raise the risk of side effects. Common nephrotoxic drugs include:
These antiviral medications (used for CMV infections) may compete with Emtricitabine for renal tubular secretion, potentially increasing levels of either drug. If you need both, your doctor should monitor kidney function and watch for side effects.
Used to treat hepatitis C, Ribavirin has a theoretical interaction with Emtricitabine through intracellular phosphorylation pathways. If you're being treated for both HIV and hepatitis C, your doctor will monitor for toxicity.
Emtricitabine has relatively few interactions with supplements and OTC drugs, but there are still a few things to keep in mind:
The good news: Emtricitabine has no significant food interactions. You can take it with or without meals, and there are no foods you need to avoid.
As for alcohol: there's no direct interaction between Emtricitabine and alcohol, but heavy drinking can damage your liver and immune system — both of which are important to protect when living with HIV. Moderate alcohol use is generally fine, but discuss your habits with your doctor.
Before starting Emtricitabine, make sure your doctor knows about:
Keeping your healthcare team informed helps them choose the safest, most effective combination of medications for you. For more on what Emtricitabine is and how to take it, see our complete overview. For side effect details, visit our side effects guide.
Emtricitabine has fewer drug interactions than many other HIV medications, but the interactions it does have are important. The biggest thing to remember: don't double up on Emtricitabine by combining standalone capsules with combination products that already contain it, and never take it with Lamivudine.
Beyond that, keeping your doctor informed about all the medications and supplements you take is the best way to stay safe. If you're looking for Emtricitabine, Medfinder can help you find it in stock near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.